These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17962606)

  • 1. NINDS clinical trials in stroke: lessons learned and future directions.
    Marler JR
    Stroke; 2007 Dec; 38(12):3302-7. PubMed ID: 17962606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.
    Savitz SI; Lew R; Bluhmki E; Hacke W; Fisher M
    Stroke; 2007 Dec; 38(12):3205-12. PubMed ID: 17975102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NINDS-sponsored clinical trials in stroke: past, present, and future.
    Marler JR
    Stroke; 2002 Jan; 33(1):311-2. PubMed ID: 11779932
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations.
    Stahl JE; Furie KL; Gleason S; Gazelle GS
    Radiology; 2003 Sep; 228(3):659-68. PubMed ID: 12954888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials.
    Young FB; Weir CJ; Lees KR;
    Stroke; 2005 Oct; 36(10):2187-92. PubMed ID: 16179579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening potential therapies: lessons learned from new paradigms used in Parkinson disease.
    Tilley BC; Galpern WR
    Stroke; 2007 Feb; 38(2 Suppl):800-3. PubMed ID: 17261742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of NINDS-sponsored studies to community-based physician involvement.
    Lindblad AS; Clemons T; Lindblad RW; Sykes R; Meador KJ; Odenkirchen JC; Hart RG
    Neurology; 2008 May; 70(19):1688-90. PubMed ID: 18057316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research priority setting: a summary of the 2012 NINDS Stroke Planning Meeting Report.
    Vickrey BG; Brott TG; Koroshetz WJ; ;
    Stroke; 2013 Aug; 44(8):2338-42. PubMed ID: 23821224
    [No Abstract]   [Full Text] [Related]  

  • 10. Funding evidence: the National Institute of Neurological Disorders and Stroke Clinical Trials Program.
    Ravina B; Janis S; Keleti J; Marler JM
    NeuroRx; 2004 Jul; 1(3):317-22. PubMed ID: 15717033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
    Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical interpretation and use of stroke scales.
    Kasner SE
    Lancet Neurol; 2006 Jul; 5(7):603-12. PubMed ID: 16781990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.
    Babady NE; Carelle N; Wells RD; Rouault TA; Hirano M; Lynch DR; Delatycki MB; Wilson RB; Isaya G; Puccio H
    Mol Genet Metab; 2007; 92(1-2):23-35. PubMed ID: 17596984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on neuropsychiatric genetics: interests of the National Institute of Neurological Disorders and Stroke.
    Small JA; Sheridan PH
    Am J Med Genet; 1994 Dec; 54(4):309-10. PubMed ID: 7726201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary of the National Institute of Neurological Disorders and Stroke conference on Emergency Neurologic Clinical Trials Network.
    Barsan WG; Pancioli AM; Conwit RA
    Ann Emerg Med; 2004 Oct; 44(4):407-12. PubMed ID: 15459625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NINDS Common Data Elements for Congenital Muscular Dystrophy Clinical Research: A National Institute for Neurological Disorders and Stroke Project.
    Lawlor MW; Iannaccone ST; Mathews K; Muntoni F; Alai-Hansen S; Odenkirchen JC; S Feldman R;
    J Neuromuscul Dis; 2018; 5(1):75-84. PubMed ID: 29480213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
    LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
    Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteplase treatment for acute stroke 2007: an effective therapeutic option at our disposal].
    Carneado-Ruiz J; Saver JL
    Rev Neurol; 2007 Jul 1-15; 45(1):42-52. PubMed ID: 17620265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.